Clinical Trial Update: CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CBG/CBD oil for chemotherapy-induced peripheral neuropathy; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• CBG/CBD Oil (cannabigerol cannabidiol oil)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Chemotherapy-Induced Peripheral Neuropathy | Phase 1 | Status: NOT_YET_RECRUITING